|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 491/10 | |
| A61K 31/4355 | |||
| A61P 25/00 |
| (11) | Number of the document | 2137192 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08735211.8 |
| Date of filing the European patent application | 2008-04-14 | |
| (97) | Date of publication of the European application | 2009-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2014-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/002929 |
| Date | 2008-04-14 |
| (87) | Number | WO 2009/127218 |
| Date | 2009-10-22 |
| (72) |
MAELICKE, Alfred, DE
|
| (73) |
Neurodyn Life Sciences Inc.,
Suite 508 NRC-INH 550 University Ave.,, Charlottetown, P.E.I., C1A 4P3,
CA
|
| (54) | Derivatives of galantamine as pro-drugs for the treatment of human brain diseases |
| Derivatives of galantamine as pro-drugs for the treatment of human brain diseases |